bioRxivSystems BiologyPreprint
Active learning-guided mechanistic modeling of CXCL9 regulation in pancreatic cancer
Bi-rong WangiD, Maaruthy YelleswarapuiD, Lucie DescampsiD, Federica EduatiiD
Abstract
Cold tumors like pancreatic cancer suffer from poor immune infiltration, limiting effective anti-tumor responses. The chemokine CXCL9 promotes immune cell recruitment, but the signaling mechanisms regulating its expression in tumor cells remain poorly understood and underexplored as targets for modulation. We present a framework that integrates active learning with mechanistic logic-ODE models to guide perturbation screenings and uncover regulators of CXCL9 in pancreatic cancer cells. Using perturbation-response data and curated prior knowledge, we trained interpretable models to identify signaling mechanisms that enhance CXCL9 expression and prioritize drug combinations. Active learning enabled data-efficient model refinement and guided informative experiments under resource constraints. Benchmarking on synthetic data and experimental validation confirmed the performance of different acquisition strategies and revealed cell line-specific regulatory differences. Our results provide insight into tumor cell-intrinsic control of CXCL9 and demonstrate how combining active learning with mechanistic modeling supports rational, targeted experimental design.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cytotoxic chemotherapy potentiates the immune response and efficacy of combination CXCR4/PD-1 inhibition in models of pancreatic ductal adenocarcinoma
A. G. Raufi, I. Pellicciotta, … G. A. Manji·bioRxiv·Dec 24, 2023
- Pancreatic cancer cells assemble a CXCL12-keratin 19 coating to resist immunotherapy
Z. Wang, R. Yan, … D. T. Fearon·bioRxiv·Sep 4, 2020
- Adipose contributes to CXCL5 regulated immune evasion in pancreatic cancer
R. M. Walsh, J. Ambrose, … M. VanSaun·bioRxiv·Aug 15, 2023
- Mutant KRAS promotes NF-kB driven CCL20 chemokine expression in pancreatic ductal adenocarcinoma
Donovan Drouillard, Marissa Davies, … Michael B. Dwinell·bioRxiv·Apr 15, 2026
- The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors
M. Rouanet, H. Lulka, … P. Cordelier·bioRxiv·Mar 5, 2020
- Tumor Cell Death Drives Tumor-Promoting IL-6+ iCAF formation via P2X7-activation
Ciarán McDonnell, Valeriya V. Zinina, … Mark R. Schmitt·bioRxiv·Mar 20, 2026